identified that CLDN18 could reversely regulate the nuclear localisation and activity of the downstream transcriptional coactivator Yes-associated protein (YAP) and thus promotes the proliferation of AT2 cells in normal lung as well as that of tumour cells found in lung adenocarcinomas thought to originate from AT2 cells (17, 72). The gene discussed is CLDN18; the disease is neoplasm.